Cancer Screening

“Lung cancer”—what first pops into your head when you hear that?

It’s important to understand the nuances of this test, along with your family history, so you can make an informed decision on when to begin testing and how frequently.

Dr. Julian Schink, GYN Oncology Chief of Cancer Treatment Centers of America, provides screening tips and recommendations for these 2 most common gynecologic cancers.

Dr Hayes, Immediate Past President of ASCO and Professor of Breast Cancer Research at the University of Michigan Comprehensive Cancer Center, explains how biomarkers offer more precise treatment opportunities for patients with breast cancer.

CancerSEEK is a noninvasive blood test that may help detect cancer in early stages, when treatment has the highest chance for success.

Liquid biopsy is a noninvasive blood test that can help identify cancerous cells or biomarkers, such as gene mutations that may respond to targeted therapies.

Biomarkers are biologic markers that indicate changes in our genes and may increase the risk of cancer.

This first-ever direct-to-consumer genetic test can provide information on potential risks to individuals who may not have access to genetic screening, but the information may be misleading without feedback from experts.

This week is Cancer Screen Week—a nationwide public health initiative to increase awareness of the benefits of early cancer detection.